Published by
@ShahidNShah
@ShahidNShah
March 12 to March 15, 2024
ExCeL London, 1 Western Gateway, London, England, E16 1XL, United Kingdom
The 14th World ADC London conference, scheduled from March 12 to March 15, 2024, marks a significant moment in the field of antibody-drug conjugates (ADCs). Recent milestones, like ENHERTU's success, Pfizer's substantial acquisition of Seagen, and FDA's approval of ELAHERE, have ignited a resurgence in ADC development. This event gathers 600+ industry leaders from companies such as AbbVie, AstraZeneca, Daiichi Sankyo, and others to discuss linker-payload optimization, target discovery, toxicity management, combination partner selection, and manufacturing advancements. It's a prime opportunity to drive ADCs to the forefront of groundbreaking therapies.
Read on worldadc-europe.com
Continue reading at orldadc-europe.com
March 13 to March 18, 2024
The Westin Hapuna Beach Resort, 62-100 Kauna'oa Drive, Waimea, 96743, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 21, 2024 at 6:20am